PND41 IMPROVEMENT IN PATIENT SATISFACTION WITH INCREASING NATALIZUMAB TREATMENT DURATION IN MULTIPLE SCLEROSIS PATIENTS IN THE UNITED STATES

Authors :: Judith J. Stephenson
Sonalee Agarwal
L Hou
K Rajagopalan
S.A. Kamat
Source :: Value in Health. (7):A373
Publisher :: International Society for Pharmacoeconomics and Outcomes Research (ISPOR). Published by Elsevier Inc.

Subjects :: medicine.medical_specialty
Natalizumab
business.industry
Health Policy
Treatment duration
Multiple sclerosis
Public Health, Environmental and Occupational Health
Physical therapy
medicine
In patient
medicine.disease
business
medicine.drug

Full Text Access

Tools